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Transforming rowth factor-ill (TGF-Ill) rapidly activated phosphorylas¢ in isolated rat hepatoeytes (half-maximal rate of activation with 
approximately 0.1 nB/ml). Removal of Ca ~" from the external medium just before TGF-Ili addition markedly attenuated phosphorylas¢ activation. 
TG F-ill ( 1 ng/ml) produced a small increase in [Ca"*]~ (approximately i 0% increase after 30 s), which appears sufficient to account for phosphorylase 
activation. These observations indicate that activation of the TGF-/]I signal tmnsduction system in laepatocytes i~linked with a small increase in 
[Ca"+]~, and external Ca "~* may contribute in part to this increase. 
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1. INTRODUCTION 
The transforming rowth factor-beta (TGF-/~) family 
comprises at least five closely related polypeptides 
which modulate growth and differentiation in a variety 
of cell types [1-3]. The prototype, now designated TGF- 
/~1, was initially purified from human platelets [4] and 
exists in the biologically active form as a homodimeric 
peptide of 25 kDa. Although originally identified by its 
ability to induce anchorage-independent growth in fi- 
broblasts [5,6], TGF-]~I has subsequently been shown 
to be a potent inhibitor of the growth of epithelial cells, 
including hepatocytes [7-10]. The mechanisms whereby 
TGF-,81 and other TGF-,B family members regulate cell 
growth are presently unknown, but appear to be medi- 
ated by specific cell surface receptors. Three types of 
TGF-,8 receptors have been identified [11-16]; types 1 
and II are glycoproteins thought o be directly involved 
in the TGF-/~ signal transduction process, while recep- 
tor 1II (betaglycan) appears to serve some other func- 
tion [17-20]. The type II receptor contains a serine/ 
threonine kinase activity in the cytoplasmic domain 
[21], unlike the type III receptor [22,23]. 
The intracellular events which follow receptor bind- 
ing of TGF-/~ are not well defined. TGF-/~I causes rapid 
phosphorylation of a number of nuclear proteins in 
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mink lung CC164 ce~ls [24], one of which is identified 
as the cyclic AMP responsive lement binding protein 
[25]. It has been reported that TGF-]~I increased inosi- 
tol 1,4,5-trisphosphate levels and promoted Ca -'~" influx 
in Rat-I cells [26,27], but these efl'ects occurred after 
several hours and were blocked by actinomycin D. The 
present study was undertaken to examine the early ef- 
fects of TGF-fll on isolated rat hepatocytes; evidence 
is presented for a rapid increase in phosphorylase a
activity which appears to be mediated through a small 
increase in [Ca2~]i. 
2. MATERIALS AND METHODS 
2.1. Materials 
TGF-Ill prepared from porcine platelcts, was purcha.sP.d from R & 
D Systems (Minneapolis, MN. USA); collagenase D was from 
Boehringer Mannheim (Indianapolis, IN, USA); fatty acid free bovine 
serum albumin (PENTEX. fraction V) was from Miles Diagnostics 
(Kankakee, IL, USA): indo-l/AM was from Molecular Probes (Junc- 
tion City, OR. USA); ¢z-D-[U-~C] glucose-l-phosphate wasfrom Du- 
Pont/NEN (Boston, MA, USA). All other eagents were of analytical 
[~rade. 
2.2. Hepatocyte prt,paratian 
Isolated hepatocytes were prepared by collagenase perfusion of 
intact liver from fed, male, Sprague-Dawley rots (175-250 B}, as de- 
scribed by Meijer et al. [28l. 
2.3. Pho~phorylase m asurement.~" 
Hepatocytes were incubated (7.5 mg dry weight/ml) in Krebs- 
Ringer bicarbonate buffer containinll 15 mM glucose and 0.2% (w/v) 
fatty acid-free bovine serum albumin (medium A). After shaking for 
30 rain at 37°C in a water bath under an atmosphere ofOv'CO, (~5:5), 
200/zl aliquots were rapidly mixed with 200/ul aliquots of buffer 
containing 50 mid MES, pH 6.1,150 mM NaF, 2~ mM F.DTA, 0.4 
M sucrose, 0.025% (v/v) Triton X-100 anti 5 mM dithiothreitol, and 
immediately frozen in liquid N,. Samples ,,,...~m stored at -80°C until 
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assayed for phosphorylase a by the procedure of Gilboe et al. [29]. 
Total phosphorylase actMty was measured in the presence of 5 mM 
AMP and 10% (v/v) ethylene glycol dimethyl ether [30]. 
2.4. Cytosolic free Ca:* measurements u htg indo-I 
Hepatoeytes were preincubated for 10 rain at 37°C (10 mg dry 
weight/ml) in medium A in a shaking water bath. lndo-1/AM was 
added (4 #M final concentration) and incubation continued for a 
further 15 rain. Hcpatocytes were centrifuged at 50 x g for 1 rain, 
resuspended at the same concentration in fresh medium A, re-centri- 
fused, and resuspendgd in medium A at a concentration f 25 mg dry 
weight/ml. Intracellular Ca :+ measurements were perforrned using an 
Hitachi F2000 fluorescence spectrophotometer, with excitation at 355 
nm, and fluorescence emission at 410 nm and 480 nm was monitored 
alternately every 0.5 s. indo.l-loaded hepatocytes (6mg dry weight/ 
ml) were preincabated in a stim.xl cuvette maintained at32°C, for 3 
rain prior to addition of growth factor or agonist. For calibration 
purposes, equential dditions of EGTA (3 ram), Tris base (10 ram), 
Triton X-100 (0.1%, v/v), and excess CaCI, (5 mM) were made [31]. 
[Ca:']~ was calculated after correction for autotluorescence, according 
to the formula [32]: 
[Ca-"]; = Kd(R-R,~I.)/(Rm.,-R) × Sta/S:. 
where Kd (250 am) is the dissociation constant for Ca:* binding to 
indo-l, R~., and R,,t, are the fluorescence ratio values under saturat- 
ing and Ca~.free conditions, respectively, and SdSb: is the ratio of 
fluorescence values for Ca:+-free/Ca-~+-boand indicator at 480 am. 
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Fig. 2. Dose-response curve for rate of activation of phosphorylase 
in hepatocytes by TGF.fll. Time courses for activation of phosphory. 
lase in hepatocytes incubated in Krebs-Ringer bicarbonate buffer 
containing 1.33 mM CaCI:, by concentrations of TGF-fll from 0.01 
to 5 ng/ml were established by removing samples for phosphorylase 
measurement from cell suspensions before, and at various times (10, 
20, 30 s) after addition of the particular concentration fTGF-fll. The 
initial rates of activation of phosphorylase, 10 s after TGF-fll addi- 
tion, are plotted as a function ofT~F-fl I concentration. Values hown 
are means +_ S.E.M. for data from 4 separate xperiments, 
3. RESULTS 
As shown in Fig. 1, TGF-~I (1 ng/ml) caused a rapid 
increase in hepatocyte phosphorylase a activity, with 
maximal activation (2.5-fold increase relative to con- 
trol) occurring between 30 s and 1 min, followed by a 
return towards control values. Total hepatocyte 
phosphorylase activity (i.e. a and b forms) was essen- 
tially unchanged by TGF-fll; values of 88.4 __ 3.7 nmol/ 
100~ 
= 60 
0~- , '  
.z: 20 :  
0 , ~ ; - i 
Time (rain) 
Fig. 1. Effect of TGF-fll on phospho~lase a activity in hepatocytes 
and dependency on external calcium. Hepatocytes were prcincubatcd 
at 37°C for 40 rain in Krebs-Ringer bicarbonate buffer containing 
1.33 mM CaCI:, and then centrifuged at 50 × g for 70 s and resu~- 
pended in Kreb~-Ringer bicarbonate buffer containing CaCh or in 
buffer without added CaCl2. The eentrifagation step was repeated 
followed by resuspension f the cells. Cells were subsequently incu- 
bated either in the presence (e) or absence (o) of CaCla for 5 rain, 
before addition of TGF-fll (I n~ml), Aliquots were removed for 
phosphorylase assay at the times indicated. Results hown are means 
_+ S.E.M, for 4 separate xperiments. 
min/mg and 93.0 _+ 3.0 nmol/mirgmg (mean +_ S.E.M. 
for 4 separate experiments) were observed before, and 
2 rain following TGF-fll, respectively. When TGF-fll 
was added to hepatocytes which had been washed twice 
and incubated for 5 rain in buffer with no added CaCI2, 
there was a rapid activation of phosphorylase (Fig. 1) 
but the maximal extent of this activation and the dura- 
tion were reduced relative to the response observed in 
the presence of external calcium. 
Fig. 2 shows initial rates of activation of phosphory- 
lase, measured 10 s after addition of TGF- pl,  plotted 
as a function of TGF-fll concentration. Phosphorylase 
activation was observed at TGF-fll concentrations a
low as 0.0i ng/ml, and the rate of activation was maxi- 
mal at 1 ng/ml. This concentration range is similar to 
that previously reported for inhibitory effects of TGF- 
,81 on epidermal growth factor-induced DNA synthesis 
in hepatocytes [10]. 
The increase in phosphorylase a by TGF-pl and its 
dependency on external Ca 2+ (Fig. 1) may indicate re- 
ceptor-activated increases in cytosolic Ca -~" from intra- 
cellular stor,=s and entry of external Ca2% as is well 
established for a:agonists and vasopressin [33,34]. Ac- 
cordingly, the effect of TGF-fll on hepatocyte [Ca2q~ 
was examined using cells loaded with the Ca2~-sensitive 
dye, indo-I [32]. As shown in Fig. 3a, TGF-fll (I nggml) 
caused an increase in the 410 nm fluorescence mission 
signal, corresponding to a calculated change in [Ca2~]j 
from 93 nM (mean value determined over a 60 s period 
prior to TGFS I  addition) to a value of approximately 
100 nM within 30 s after TGF-fll addition. Overall, in 
6 determinations from three hepatocyte preparations, 
treatment with TGF-fll (i ng/ml) for 30 s increased 
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Fig. 3, Comparison ofchanges in cytosolic Ca 2~ concentration elicited 
by TGF-,61 and by low and high concentrations of phenylcphrine 
(PE), with corresponding changes in phosphorylase a activity. Panels 
(a) and (b) show the changes in fluorescence emission at 410 nm in 
indo-l-loaded hepatocytes, following addition of TGF-fl or phenylg- 
phrine, respectively. In panel (b) the indicated addition of PE were 
made to the same cavette approximately 3 rain apart; part of the 
intervening trace was deleted for presentation. Calculated intracellular 
Ca 2* concentrations [Ca-~']~, are as indicated. Panel (c) shows changes 
in ph0sphorylase activity at the indicated times following addition of 
either TGF-]~ (1 ng/ml, o), or PE (50 aM, e). 
[Ca:+]~ from 112 + 8 nM to 126 +_ 9 nM (means + S.E.M. 
for control and TGF-fll-treated ceUs, respectively). The 
increase in [Ca-~+]~ was significant (P < 0.01) when ana- 
lyzed by the Paired Student's t-test. The relevance of 
this relatively small change was assessed by determining 
whether the ~;-adrenergie agonist0 phenylephrine, 
could, at a suitably low concentration, elicit a similar 
activation of phosphorylase with a correspondingly 
small increase in [Ca~-+];. It is well established that ~q- 
adrener~ic agonists promote phosphoinositide hydroly- 
sis causing mobilization of Ca z+ from intracellular 
stores and en~.ry of external Ca -~* [33,34]; the increase in 
[Ca:~']~ activates phosphorylase kinase which in turn, 
promotes conversion of phosphorylase b to the a form. 
Fig. 3b indicates that a low concentration f phenyleph- 
rine (50 nM) caused a small increase in [Ca2÷]i concen- 
tration after 30 s0 of similar magnitude (approximately 
10% increase in duplicate determinations) to that ob- 
served with TGF-~I in Fig. 3a. A higher concentration 
of phenylephrine (10 AiM) added subsequently to the 
low concentration asshown in Fig. 3b caused a larger 
increase in [Ca~-*]t as expected. It appears however from 
the data shown in Fig. 3c, that phenylephrine (50 nM), 
was capable of activating phospho~lase to the same 
extent observed with TGF-/~I (1 ng/ml), suggesting that 
the relatively small increase in [Ca~'+]i in response to 
TGF-/~I is sufficient o account for the activation of 
phosphorylase. 
4. DISCUSSION 
The present restilts demonstrate hat TGF-pl pro- 
duces a rapid increase in phosphorylase a aetivity in 
hepatocytes (Fig. 1), and the concentration range over 
which such activation occurs (Fig. 2), is similar to the 
concentration range over which TGF-]~I inhibits epi- 
dermal growth factor-induced DNA synthesis in rat 
hepatocytes [10]. The change in phosphorylase activity 
is rapid (maximal by 30 s) and is one of the earliest 
observed changes in a cellular esponse to TGF-]~I. 
Evidence is presented in Fig. 3a for a small increase 
in [Ca2+]~ in hepatocytes xposed to TGF-fll for 30 s. 
Furthermore, removal of external Ca 2" from the me- 
dium just prior to TGir-,gl addition, markedly attenu- 
ates the phospho~'lase activation (Fig. 1), suggesting 
that entry of external Ca -'+, as well as mobilization of 
Ca 2÷ from internal stores, may contribute to the eleva- 
tion of cytosolic Ca ~-' underlying phosphorylase activa- 
tion. Entry of external Ca 2+ into the hepatoeytes i  
known to be required for a sustained activation of 
phosphorylase in response to phenylephrine and vase. 
pressin [33,34]. Although the increase in [Ca-~*]~ elicited 
by TGF-/~I is relatively small, phenylephrine, whose 
ability to promote changes in intracellular Ca "-+ levels 
and activate phosphorylase is well established [33,34], 
was capable of increasing hepatocyte phosphorylase ac- 
tivity to the same extent as TGF-/~I, with a similarly 
small increase in [Caa+]~ (Fig. 3). This finding is consis- 
tent with previous data comparing vasopressin dose- 
response curves for phosphorylase activation and in- 
crease in [Ca'~*]~ in hepatocytes, which suggested that 
phosphorylase kinase can be activated at very low Ca 2÷ 
levels [35]. 
In summary, the ability of TGF-/~I to promote rapid 
activation of hepatocyte phosphorylase activity, associ- 
ated with a small increase in [Ca2+]~, represents one of 
the earliest reported intracellular effects of TGF-~I. 
The rapidity of these changes indicates a close coupling 
with events occurring upon binding of TGF-fll to the 
receptor, and elucidation of the mechanisms responsible 
for these changes in [Ca-~*]~ should therefore provide 
insight into the TGF-/~I signal transduction system. 
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